|4Feb 3, 6:15 PM ET

Kimball Aaron 4

4 · Zymergen Inc. · Filed Feb 3, 2022

Insider Transaction Report

Form 4
Period: 2022-02-01
Kimball Aaron
Chief Technology Officer
Transactions
  • Sale

    Common Stock

    2022-02-01$5.06/sh25,000$126,605770,283 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.
  • [F2]Transaction executed in multiple trades at prices ranging from $4.93 to $5.25 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Documents

1 file
  • 4
    wf-form4_164393010936470.xmlPrimary

    FORM 4